Post-marketing Surveillance Study of the Effectiveness and Safety of new Oral Antivirals for outpatients with mild-moderate COVID-19. (ESOA-19)

First published 18/07/2022

Last updated 05/06/2025

EU PAS number:

EUPAS48186

Study

Planned

Documents

Study protocol

Study results

Molnupiravir results | Pharmacological Reports Journal

English (1.16 MB - PDF)View document

Study report

Other information

Publications

Study publications

ENCePP Seal

This study has been awarded the ENCePP seal

ENCePP Seal documents

Conflicts of interest of investigators

EUPAS48186-48194

English (160.73 KB - PDF)View document

Composition of steering group and observers

Composition of Steering Group and Observers_signed

English (400.67 KB - PDF)View document

Secondary tabs